A Revolutionary Era in Advancing Precision Immuno-oncology; Role of Circulating Tumor Cells

Overview

Journal J Liq Biopsy

Date 2025 Mar 3

PMID 40027303

Authors

Nazila Bahmaie

Ozen Ozensoy Guler

Ender Simsek

Affiliations

Soon will be listed here.

Abstract

Despite a substantial progress in the development of strategies against cancer, cancer still remains a major global health issue due to a high recurrence rate, and severe side effects, leading basic medical scientists and clinical specialists toward more efficient diagnostics, prognostics, and therapeutics. Therefore, there is an imperative need for a comprehensive understanding on the cellular immunopathophysiology involved in the tumor microenvironment. In addition, results from a wide range of studies depicted that an aberration in the cellular mechanisms and immunopathophysiological interactions like Circulating Tumor Cells (CTCs) plays an indispensable role in the metastasis and tumor progression, revolutionizing cancer management by offering non-invasive detection methods and a real-time monitoring of tumor dynamics. Moreover, CTCs can clarify the tumor heterogeneity and the evolution of resistance mechanisms, aiding in the early detection of tumors and informing personalized treatment strategies. An increase in CTCs count can be associated with a worsened cancer prognosis, providing promising biomarkers for tumor phenotyping, tumor spreading or relapse, and monitoring the treatment response in patients with cancer. Hence, this systematic review aims to highlight the diagnostic, prognostic, and therapeutic potentials of CTCs, necessitating further investigations and an interdisciplinary collaboration among basic medical scientists and oncologists to address the current gaps in the strategies of cancer management, precisely improving patient-care and optimized clinical outcomes.

References

Liu X, Song J, Zhang H, Liu X, Zuo F, Zhao Y . Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell. 2023; 41(2):272-287.e9. DOI: 10.1016/j.ccell.2023.01.001. View

Hu M, Wang Z, Wu Z, Ding P, Pei R, Wang Q . Circulating tumor cells in colorectal cancer in the era of precision medicine. J Mol Med (Berl). 2021; 100(2):197-213. PMC: 8770420. DOI: 10.1007/s00109-021-02162-3. View

Eslami-S Z, Cortes-Hernandez L, Thomas F, Pantel K, Alix-Panabieres C . Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade. Br J Cancer. 2022; 127(5):800-810. PMC: 9427839. DOI: 10.1038/s41416-022-01819-1. View

Siegel R, Miller K, Wagle N, Jemal A . Cancer statistics, 2023. CA Cancer J Clin. 2023; 73(1):17-48. DOI: 10.3322/caac.21763. View

Rupp B, Ball H, Wuchu F, Nagrath D, Nagrath S . Circulating tumor cells in precision medicine: challenges and opportunities. Trends Pharmacol Sci. 2022; 43(5):378-391. DOI: 10.1016/j.tips.2022.02.005. View

Vidlarova M, Rehulkova A, Stejskal P, Prokopova A, Slavik H, Hajduch M . Recent Advances in Methods for Circulating Tumor Cell Detection. Int J Mol Sci. 2023; 24(4). PMC: 9959336. DOI: 10.3390/ijms24043902. View

Ricciardi E, Giordani E, Ziccheddu G, Falcone I, Giacomini P, Fanciulli M . Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach. Int J Mol Sci. 2023; 24(4). PMC: 9962821. DOI: 10.3390/ijms24044014. View

Espejo-Cruz M, Gonzalez-Rubio S, Espejo J, Zamora-Olaya J, Alejandre-Altamirano R, Prieto-Torre M . Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Int J Mol Sci. 2023; 24(3). PMC: 9916725. DOI: 10.3390/ijms24032558. View

Palmieri M, Frullanti E . Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era. Med Sci (Basel). 2023; 11(1). PMC: 9844315. DOI: 10.3390/medsci11010008. View

10.

Jin D, Qian L, Xia J, Zhang R, Yang G, Zhang L . In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer. Med Oncol. 2023; 40(4):113. DOI: 10.1007/s12032-023-01977-z. View

11.

Blanchi J, Laroche-Clary A, Le Loarer F, Bonhomme B, Italiano A . Prognostic impact of circulating tumor cells in patients with soft-tissue sarcomas: a prospective study. Cancer Commun (Lond). 2023; 43(3):391-394. PMC: 10009659. DOI: 10.1002/cac2.12389. View

12.

Zhou Q, Liu X, Li J, Tong B, Xu Y, Chen M . Circulating tumor cells PD-L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non-small-cell lung cancer. Thorac Cancer. 2023; 14(5):470-478. PMC: 9925337. DOI: 10.1111/1759-7714.14767. View

13.

Yeo D, Kao S, Gupta R, Wahlroos S, Bastian A, Strauss H . Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging. Front Oncol. 2023; 13:1141228. PMC: 10083432. DOI: 10.3389/fonc.2023.1141228. View

14.

Aktar S, Hamid F, Gamage S, Cheng T, Parkneshan N, Lu C . Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with Colorectal Carcinoma. Int J Mol Sci. 2023; 24(5). PMC: 10003441. DOI: 10.3390/ijms24055051. View

15.

Wang X, Zhang S, Jin D, Luo J, Shi Y, Zhang Y . μ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial. Cancer Commun (Lond). 2023; 43(3):365-386. PMC: 10009666. DOI: 10.1002/cac2.12408. View

16.

Papadaki M, Monastirioti A, Apostolopoulou C, Aggouraki D, Papadaki C, Michaelidou K . TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications. Cancers (Basel). 2022; 14(4). PMC: 8869985. DOI: 10.3390/cancers14041053. View

17.

Heidrich I, Abdalla T, Reeh M, Pantel K . Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer. Cancers (Basel). 2021; 13(18). PMC: 8469158. DOI: 10.3390/cancers13184500. View

18.

Mastromarino M, Parini S, Azzolina D, Habib S, De Marni M, Luise C . Liquid Biopsy Detecting Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer: Preliminary Results of a Pilot Study. Biomedicines. 2023; 11(1). PMC: 9855397. DOI: 10.3390/biomedicines11010153. View

19.

Sawabata N . Circulating Tumor Cells: From the Laboratory to the Cancer Clinic; A Closing Comment. Cancers (Basel). 2023; 15(3). PMC: 9913766. DOI: 10.3390/cancers15030939. View

20.

Tellez-Gabriel M, Knutsen E, Perander M . Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies. Int J Mol Sci. 2020; 21(24). PMC: 7763984. DOI: 10.3390/ijms21249457. View